Kraig Biocraft Laboratories Expands Operational Footprint in Vietnam
ANN ARBOR, Mich., Aug. 17, 2022 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)…
News
Tilray Medical Bolsters Market Leading Position in Europe With Market Authorization in Poland
Polish Ministry of Health Approves Tilray Branded Medical Cannabis for Pharmaceutical Distribution in Addition to…
Kamada Reports Second Quarter and First Half 2022 Financial Results; Significant Growth Driven by Multiple Catalysts Expected in Second Half of 2022; Reiterates 2022 Revenue and Profitability Guidance
Second Quarter 2022 Revenues were $23.6 Million; First Half 2022 Revenues of $51.7 Million Increased…
Grom Social’s Top Draw Animation Secures $1.3MM in New Assignments
Grom Subsidiary Continues to Deliver Premium Animation Production Services to Global Entertainment Content Suppliers BOCA…
Raymond James Selects FactSet as the Market Data Provider for U.S. Financial Advisors
FactSet solutions deployed to over 7,500 Raymond James wealth management professionals across the United States….
Melissa Partners with ID-Pal to Launch Melissa ID for Seamless Contact Verification in Real-time
New app runs safe, secure background checks in parallel with data entry, strengthening identity verification…
APENFT to Support Potential Ethereum Hard Fork and NFT Trading on the New Chain
Singapore, Singapore–(Newsfile Corp. – August 17, 2022) – APENFT Marketplace has announced support for the…
DGTL Holdings Inc. Reports Change of Auditor Appointment
[DATELINE]DGTL Holdings Inc. (TSXV: DGTL) (“DGTL” or the “Company“) has changed its appointed auditor from…
Reklaim Announces Results of Annual General and Special Shareholders Meeting and Shareholder Approval of Amended Option Plan
New York, New York–(Newsfile Corp. – August 17, 2022) – Reklaim Ltd. (OTCQB: MYIDF) (TSXV:…
InvesTech Holdings and Microsoft Jointly Launch Two Enterprise Digital Transformation Solutions
HONG KONG, Aug 17, 2022 – (ACN Newswire) – InvesTech Holdings Limited (“InvesTech Holdings”, together…
CNERGENZ Posts RM76.58 Million in Revenue for 2Q FY2022
PENANG, Malaysia, Aug 17, 2022 – (ACN Newswire) – CNERGENZ Berhad, an established electronics manufacturing…
AtomicMind Launches College Admissions Technology Platform for a Personalized and Comprehensive College Application Experience
Enhanced collaboration between experienced counselors and applicants facilitates student success by fostering greater engagement and…
Burrow and Bennett Double Down In Sports Illustrated’s Dual Cover Football Preview Issue
Inside the Football Preview Issue, available at SI.com and on newsstands tomorrow: Can marquee quarterbacks…
NanoDx and SkyWater Announce First Commercially Ready Nano Biosensor to Yield Protein Response
Milestone in real-time, point-of-care diagnostics for traumatic brain injury and other disease applications BOSTON &…
Elif Tutuk Joins AtScale as New VP of Product
Innovative Data and Analytics Leader to Further Strengthen Product Development BOSTON–(BUSINESS WIRE)–#AI—AtScale, the leading provider…
Tellius to Showcase AI-Driven Decision Intelligence Platform at 2022 Gartner Data and Analytics Summit
Company will present on stage in joint customer speaking session focused on decision intelligence in…
Genesis Announces New Leadership Team
Michael Moro to Step Down as CEO; Derar Islim Appointed Interim Chief Executive Officer Financial…
NHS Forth Valley migrates to the latest version of CCube Solutions’ EDRMS, accomplishing its ‘paper lite’ strategy to enhance patient care
August 17, 2022 – CCube Solutions announces today that NHS Forth Valley has successfully completed…
MQTT X CLI Makes Its Debut – Executing MQTT Operations Has Never Been Easier
MORGAN HILL, CA – EMQ, a leading global provider of open-source IoT data infrastructure solutions,…
Tessa Therapeutics Doses First Patient in Phase 1b Clinical Trial Investigating TT11 in Combination with Nivolumab for the Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma (cHL)
Phase 1b clinical trial (ACTION) designed to evaluate TT11 as a potential second-line therapy TT11,…